Modeling Drug and Radiation Resistance with Patient-Derived Organoids: Recent Progress, Unmet Needs, and Future Directions for Lung Cancer

Dahye Lee, Yoonjoo Kim, Da Hyun Kang, Chaeuk Chung, Alexander Dietrich · 2025

Read Modeling Drug and Radiation Resistance with Patient-Derived Organoids: Recent Progress, Unmet Needs, and Future Directions for Lung Cancer by Dahye Lee, Yoonjoo Kim, Da Hyun Kang, Chaeuk Chung, Alexander Dietrich (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12731509.txt.

Description

Dahye Lee and co-authors review, in a 2025 paper, a lab tool for studying why lung cancer stops responding to treatment. Chemo, targeted drugs, and radiation are core care, but many tumors learn to resist them, and new drugs face the same problem. The tool is a small tumor grown in the lab from a patient's own cancer cells.

Such grown tumors keep many traits of the real tumor, in form, cell type, and gene pattern. That makes them useful for testing drugs, tracing how resistance grows, and hunting for new targets. The review also notes a key flaw. Plain grown tumors lack parts of the tissue around a real tumor, such as immune and support cells. The authors set out what must improve for the tool to guide care well.

Catalog record

CREATORDahye Lee, Yoonjoo Kim, Da Hyun Kang, Chaeuk Chung, Alexander Dietrich
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12731509

Browse the full library · About the Tower of Babel